Lowmolecularweightheparinsodium(LMWH)isawidelyusedanticoagulantdrugthathasgainedsignificantattentioninrecentyearsduetoitsefficacyandsafetyprofileinthetreatmentofthromboticdisorders.Theproductionofthed
HeparinsodiumAPIsupplierisakeyplayerinthepharmaceuticalindustry.Heparinsodiumiswidelyusedintreatingmanycardiovasculardiseasessuchasdeepveinthrombosis,coronaryarterythrombosis,pulmonaryembolism,andacut
Chondroitinsulfatesodiumapimanufacturerisoneofthepopularnewmaterialmanufacturersinrecentyears.Chondroitinsodiumproducedbyitisanewdrugrawmaterialinthecurrentmedicalfield.Chondroitinsodiumisakindofpolym
Heparinsodiumisananticoagulantmedicationthatiscommonlyusedforthetreatmentofdeepveinthrombosis(DVT)andpulmonaryembolism(PE).Itisalsousedforprophylaxisofthromboemboliceventsaftersurgeryorinbedriddenpati
HeparinsodiumAPIintermediatesarethemaincomponentsofheparinobtainedaftersimplepurificationofcrudeheparinandinactivationofbacteriaandviruses.Theyarenothighpurityandcannotbedirectlyprocessedintostandardh